Harry and Jeanette Weinberg Cancer Institute at Franklin Square

Baltimore, Maryland 21237

0 studies enrolling now · 5 studies all time

What they study most

DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, HER2 Positive Breast Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, de Novo DLBCL

Studies at this site

• A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer — Completed
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed
• TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy — Stopped early
• Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients — Stopped early
• Study of XL999 in Patients With Previously Treated Ovarian Cancer — Stopped early